Global Interventional Neurology Devices Market Research Report 2022

Interventional neurology refers to endovascular, catheter-based techniques using fluoroscopy and angiography to diagnose and treat vascular disease of the central nervous system. Neurointerventional procedures use imaging technology and are minimally invasive, meaning they can be accomplished through small incisions, rather than open surgery.
Due to the COVID-19 pandemic, the global Interventional Neurology Devices market size is estimated to be worth US$ 2060.7 million in 2021 and is forecast to a readjusted size of US$ 3159.5 million by 2028 with a CAGR of 5.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Interventional Neurology Devices market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Interventional Neurology Devices landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Only specific brain, neck and spine conditions can be treated with a neurointerventional approach. Strokes, aneurysms and spinal compression fractures are some of the most common conditions an interventional neurologist will treat.
This report focuses on Interventional Neurology Devices volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Interventional Neurology Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Interventional Neurology Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Aneurysm Coiling and Embolization Devices
Angioplasty Devices
Micro Support Devices
Neurothrombectomy Devices
Segment by Application
Hospital
Ambulatory Care Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Abbott
DePuy Synthes
Medtronic
Stryker
Terumo
Acandis
Bayer
Boston Scientific
Biosensors International
evonos
Merit Medical Systems
MicroPort Scientific
Neurosign
Penumbra
Spiegelberg
Surtex Instruments